Protracted-release adminstration forms containing clindamycin palmitate

US5607685A · kind A · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Monika Cimbollek · Mannheim, DE
• Berthold Nies · Kassel, DE

Key dates

• Filing date: Feb 8, 1995
• Grant date: Mar 4, 1997
• Expiry date: Feb 8, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61L2300/406
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of clindamycin palmitate for the production of pharmaceutical administration forms having a protracted release of the antibiotic active compound clindamycin, and corresponding administration forms which are preferably used in the form of shaped implants.